# A Study to Evaluate Comparative Bioavailability of BMS-986278 in Healthy Participants

> **NCT06715683** · PHASE1 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 48 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** BMS-986278 Batched method, Dose A
- **DRUG:** BMS-986278 Batched method, Dose B
- **DRUG:** BMS-986278 Continuous method

## Key facts

- **NCT ID:** NCT06715683
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-12-12
- **Primary completion:** 2025-03-16
- **Final completion:** 2025-03-16
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2025-04-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06715683

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06715683, "A Study to Evaluate Comparative Bioavailability of BMS-986278 in Healthy Participants". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06715683. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*